Andrew Shao

Andrew Shao

executive unknown

Andrew Shao serves as the senior vice-president of global regulatory and scientific affairs at Niagen Bioscience, a company that specializes in NAD+ supplements. He recently responded to new research on NAD+ levels, emphasizing that while the findings may shift perceptions, they do not fundamentally change the importance of understanding NAD+ dynamics in tissue, particularly in the context of consumer health and wellness.

Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
0
Power
0$
Sentiment
0.00
Countries Mentioned

No country-level mention data available.

Interactive World Map

Each country's color is based on "Mentions" from the table above.